We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$314M
AUM Growth
+$47.8M
Cap. Flow
+$36.7M
Cap. Flow %
11.68%
Top 10 Hldgs %
60.02%
Holding
166
New
24
Increased
38
Reduced
50
Closed
13

Sector Composition

Rank Sector Weight
1 Communication Services 36.85%
2 Consumer Discretionary 9.71%
3 Healthcare 8.08%
4 Energy 7.33%
5 Real Estate 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.08T
$70.3M 22.41%
1,513,340
+36,140
+2% +$1.69M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.07T
$42.9M 13.65%
943,100
LZB icon
3
La-Z-Boy
LZB
$1.65B
$17.6M 5.62%
542,726
-200
-0% -$5.61K
HEDJ icon
4
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$14M 4.47%
450,800
-200
-0% -$6.48K
BXMT icon
5
Blackstone Mortgage Trust
BXMT
$2.81B
$10.7M 3.42%
333,416
-11,874
-3% -$370K
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$7.73M 2.46%
31,814
IBB icon
7
iShares Biotechnology ETF
IBB
$9.55B
$6.73M 2.14%
65,073
-7,092
-10% -$698K
XBI icon
8
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$6.33M 2.01%
81,957
+44,231
+117% +$3.14M
KREF
9
KKR Real Estate Finance Trust
KREF
$471M
$6.11M 1.95%
+280,942
New +$6.17M
AMZN icon
10
Amazon
AMZN
$2.48T
$5.9M 1.88%
+121,860
New +$5.81M
RSX
11
DELISTED
VanEck Russia ETF
RSX
$5.58M 1.78%
290,965
-600
-0.2% -$12K
GLD icon
12
SPDR Gold Trust
GLD
$131B
$5.52M 1.76%
46,740
-735
-2% -$88K
MO icon
13
Altria Group
MO
$125B
$4.65M 1.48%
61,916
-10,279
-14% -$752K
GPC icon
14
Genuine Parts
GPC
$17.9B
$4.48M 1.43%
47,940
TMO icon
15
Thermo Fisher Scientific
TMO
$214B
$4.04M 1.29%
23,134
-2,321
-9% -$390K
INTC icon
16
Intel
INTC
$435B
$3.86M 1.23%
114,338
-132
-0.1% -$4.72K
EFA icon
17
iShares MSCI EAFE ETF
EFA
$76.8B
$3.83M 1.22%
58,700
-95
-0.2% -$6.15K
BMY icon
18
Bristol-Myers Squibb
BMY
$130B
$3.8M 1.21%
68,229
-4,191
-6% -$228K
ATVI
19
DELISTED
Activision Blizzard
ATVI
$3.69M 1.18%
64,146
-1,044
-2% -$57.7K
WTW icon
20
Willis Towers Watson
WTW
$29.9B
$3.65M 1.16%
25,033
-1,492
-6% -$208K
CW icon
21
Curtiss-Wright
CW
$26.9B
$3.6M 1.15%
39,139
-611
-2% -$55.1K
MTSI icon
22
MACOM Technology Solutions
MTSI
$19B
$3.41M 1.09%
61,173
-6,233
-9% -$336K
MRK icon
23
Merck
MRK
$326B
$3.4M 1.08%
55,121
-6,068
-10% -$369K
RGNX icon
24
Regenxbio
RGNX
$615M
$3.32M 1.06%
168,020
+131,020
+354% +$2.54M
BIIB icon
25
Biogen
BIIB
$30.4B
$3.05M 0.97%
11,232
+4,812
+75% +$1.27M

Similar funds

ArchPoint Investors's Q2 2017 Portfolio in Review

As of Q2 2017, ArchPoint Investors held 166 positions worth $314M, up 18% from $266M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

ArchPoint Investors deployed $36.7M of net new capital in Q2 2017, opening 24 new positions and adding to 38 existing holdings. Its largest new stake was KKR Real Estate Finance Trust: 280,942 shares worth $6.11M.

By sector, the portfolio is most concentrated in Communication Services at 37% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $1.06M trimmed.

  • ArchPoint Investors's largest Q2 2017 buy was KKR Real Estate Finance Trust: 280,942 shares worth $6.11M.
  • ArchPoint Investors added most to State Street SPDR S&P Biotech ETF in Q2 2017, an estimated $3.14M increase.
  • ArchPoint Investors's biggest Q2 2017 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $1.06M.
  • ArchPoint Investors fully exited iShares MSCI Mexico ETF in Q2 2017, selling an estimated $1.74M.
  • ArchPoint Investors's ten largest holdings make up 60% of its $314M portfolio in Q2 2017.
  • ArchPoint Investors opened 24 new positions and closed 13 in Q2 2017.
  • ArchPoint Investors's portfolio value rose 18% quarter-over-quarter to $314M.

Based on ArchPoint Investors's 13F filing for Q2 2017, filed 3 Aug 2017.